| Autor: |
Churchill, L., Graham, A. G., Shih, C-K., Pauletti, D., Farina, P. R., Grob, P. M. |
| Zdroj: |
Inflammopharmacology; June 1996, Vol. 4 Issue: 2 p125-135, 11p |
| Abstrakt: |
Human cyclo-oxygenase-1 (hCOX-1) and-2 were expressed in stable transfected COS A.2 cells and in insect cells using a Sf9 baculovirus expression system. Inhibition of COX activity was examined using both whole cell and microsomal assays. Ibuprofen, naproxen, 6-MNA, diclofenac and indomethacin were selective for hCOX-1 or were equipotent inhibitors for COX-1 and COX-2. Piroxicam was equally inhibitory for both enzymes in the whole cell assay while it preferentially inhibited hCOX-2 in the microsomal assay. However, maximal inhibition of hCOX-2 by piroxica plateaued at 60%. Nimesulide was equipotent in the whole-cell assay but was five-fold selective for hCOX-2 in the microsomal assay. Meloxicam preferentially inhibited hCOX-2 in the whole cell assay at concentrations of 0.01 to 1 μmol/L but was an equipotent inhibitor of both enzymes at higher concentrations. In the microsomal assay, meloxicam exhibited high selectivity for hCOX-2 (75-fold). The preferential inhibition of hCOX-2 by meloxicam may explain the favourable gastrointestinal profile observed for meloxicam compared with other NSAIDs. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink